- National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United StatesDavid P Durham
Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, Yale University, New Haven, CT 06511
Proc Natl Acad Sci U S A 113:5107-12. 2016..Our results show that if policies promoting nonavalent vaccine implementation and expansion of coverage are coordinated across multiple states, all states benefit both in health and in economic terms...
- Dengue dynamics and vaccine cost-effectiveness in BrazilDavid P Durham
Yale School of Public Health, Yale University, New Haven, CT, United States
Vaccine 31:3957-61. 2013..Our results demonstrate that at the relatively low vaccine efficacy from the recent Phase 2b dengue vaccine trials, age-targeted vaccination may still be cost-effective provided the total vaccination cost is sufficiently low. ..
- Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus typesDavid P Durham
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520 8034, USA
J Infect Dis 206:1291-8. 2012..Epidemiological data on HPV infections has been repeatedly interpreted as inconsistent with cross-immunity...
- Evaluating the effectiveness of localized control strategies to curtail chikungunyaMartial L Ndeffo-Mbah
Department of Epidemiology of Microbial Disease, Yale School of Public Health, New Haven, CT, USA
Sci Rep 6:23997. 2016....